Skip to search formSkip to main contentSkip to account menu

basimglurant

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Low Potential of Basimglurant to Be Involved in Drug-Drug Interactions: Influence of Non–Michaelis-Menten P450 Kinetics on Fraction Metabolized
Basimglurant, a novel mGlu5-negative allosteric modulator under development for the treatment of major depressive disorder, is… 
2016
2016
Basimglurant, an mGluR5-Selective Negative Allosteric Modulator, Dose Not Reduce Pain but Alleviate Pain Related Anxiety-Like Behavior (P4.065)
Objective:This study investigated the effects of a single administration of basimglurant, a negative allosteric modulator (NAM… 
2015
2015
SODIUM NITROPRUSSIDE AS A FAST-ACTING ANTIPSYCHOTIC AGENT
Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate) is an ion-pair salt of pyridoxine (vitamin B6) and 2-pyrrolidone… 
2015
2015
T1. THE ANTIDEPRESSANT ACTIVITY OF BASIMGLURANT, A NOVEL MGLU5-NAM; A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY IN THE ADJUNCTIVE TREATMENT OF MDD
Background: Therapies targeting the glutamatergic system are known to be efficacious in the treatment of mood disorders… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)